@openeurope.org.uk 7 years ago
The view from Brussels: how do think tanks in Brussels see Brexit talks unfolding in 2018?
@TheNewEuropean 7 years ago
Failure to complete the first phase of Brexit negotiations is costing UK pharmaceutical companies "an enormous amount of money", industry representatives have warned http://www.theneweuropean.co.uk/top-stories/pharmaceutical-industry-brexit-regulations-1-5308539 https://t.co/NIS79IbJfZ
@openeurope.org.uk 8 years ago
How to secure a friendly Brexit?